Implementation of the Medicare Drug Price Negotiation Program (On-Demand Webinar)
Closed captions are available.
Overview: On June 30, 2023, CMS issued its final guidance memorandum on the implementation of the Inflation Reduction Act Medicare Drug Price Negotiation Program for the Initial Price Applicability Year of 2026. This memorandum is the latest development in the accelerated implementation of the negotiation program, issued just four months after CMS released an initial draft of the guidance memorandum, which generated substantial stakeholder feedback. In this webinar, participants hear the reactions to the final guidance from Margaux Hall of Ropes & Gray, LLP and Clay Willis of Berkeley Research Group. The speakers also provide insights into key considerations for manufacturers heading into the negotiation process for the initial year and what this may mean for later years of the program.
Margaux Hall, Attorney, Ropes & Gray LLP
Clay Willis, Director, Berkeley Research Group
CLE: AHLA’s webinars are pre-approved for CLE credit in the following states: AL, AR, CA, GA, IL, IN, KS, ME, MI, MS, NC, NE, NJ, OH, OK, PA, RI, SC, TN, TX, UT, VA, VT, WI, and WV. Please refer to the Distance Learning CLE State Chart on our Continuing Education Page to review the reporting procedure in these and other states.
CPE: AHLA is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be addressed to the National Registry of CPE Sponsors, 150 Fourth Avenue North, Nashville, TN 37219-2417. Website: www.nasba.org. For further information, please visit our Continuing Education Page.
AHLA is seeking CPE credits for live and on demand webinars. The maximum number of credits available is 1.80.